Courts in the U.S. and Germany have ruled in favor of Nobel Biocare, which is defending its NobelGuide software and surgical guide against claims of patent infringement by Materialise Dental, makers of SimPlant and SurgiGuide.
On April 15, the German Federal Patent Court invalidated all relevant claims of Materialise's patent. Materialise said it would appeal the decision.
In a related U.S. lawsuit last month, the U.S. District Court for the Central District of California in Santa Ana, CA, ruled that Nobel Biocare does not infringe any patent of Materialise.
"We want to stress that our customers will always be able to use our products, regardless of the outcome of the patent case," said Materialise CEO Bart Swaelens in a press release.
Copyright © 2009 DrBicuspid.com
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
